Temasek co-leads $35m pre-Series B round in China's Lupeng Pharma

Temasek co-leads $35m pre-Series B round in China's Lupeng Pharma

16 November, 2022

Lupeng Pharmaceutical Temasek

Printed by Unregistered user on Tue, 22 Jul 2025 20:37:12 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Temasek said to be weighing sale of Advanced MedTech at around $1b valuation

Venture Capital

Temasek's EvolutionX expects more India activity in 2023 as venture debt turns hot

Read more from Greater China

Chinese medical devices startup BrioHealth Solutions bags $100m

Venture Capital

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal